CLASS II Device recall · Reported 8 Feb 2017 · FDA Enforcement Report

SwishTapered Implant recalled by Implant Direct Sybron

Implant Direct Sybron Manufacturing is recalling SwishTapered Implant, distributed in California, Maine, New Mexico, Ohio, Oregon, Texas. The recall was initiated on 12 Dec 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes933308 Lot # 73241
Quantity recalled17

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1112-2017
FDA event ID
76111
Recalling firm
Implant Direct Sybron Manufacturing, Westlake Village, CA
Classification
Class II
Status
Terminated
Recall initiated
12 Dec 2016
FDA classified
28 Jan 2017
Reported
8 Feb 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

12 Dec 2016Recall initiated by company
28 Jan 2017Classified by FDA+47 days
8 Feb 2017Published in enforcement report+11 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The extender product code (9037-03) that is packaged with the SwishTapered (Part Number 933308; Lot Number 73241) Implant was packaged in the incorrect position. This discrepancy may lead to the possibility of extender not seating properly on the implant, which may lead to micro-leakage and a possible infection to the patient.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

SwishTapered Implant

Where it was distributed

U.S. distribution to the following; NM, TX, CA, OR, OH, ME. Foreign distribution to the following; Netherlands.

CaliforniaMaineNew MexicoOhioOregonTexas

Questions about this recall

Why was it recalled?

The extender product code (9037-03) that is packaged with the SwishTapered (Part Number 933308; Lot Number 73241) Implant was packaged in the incorrect position. This discrepancy may lead to the possibility of extender not seating properly on the implant, which may lead to micro-leakage and a possible infection to the patient.

Which lots are affected?

933308 Lot # 73241

Where was it sold?

U.S. distribution to the following; NM, TX, CA, OR, OH, ME. Foreign distribution to the following; Netherlands.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Implant Direct Sybron Manufacturing

All 33

Other Other Medical Devices recalls

All 13,908